Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | flap structure-specific endonuclease 1 | Starlite/ChEMBL | No references |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Trypanosoma brucei | exonuclease, putative | flap structure-specific endonuclease 1 | 380 aa | 322 aa | 24.5 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | Flap nuclease, putative | 0.0031 | 1 | 1 |
Echinococcus granulosus | expressed protein | 0.001 | 0.1535 | 0.1535 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0031 | 1 | 1 |
Echinococcus granulosus | ferritin | 0.001 | 0.1535 | 0.1535 |
Schistosoma mansoni | ferritin light chain | 0.001 | 0.1535 | 0.1746 |
Schistosoma mansoni | ferritin | 0.001 | 0.1535 | 0.1746 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0031 | 1 | 1 |
Mycobacterium ulcerans | bacterioferritin BfrA | 0.001 | 0.1535 | 0.5 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0031 | 1 | 1 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0031 | 1 | 1 |
Trichomonas vaginalis | ferritin, putative | 0.001 | 0.1535 | 0.1535 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0031 | 1 | 1 |
Echinococcus multilocularis | expressed protein | 0.001 | 0.1535 | 0.1535 |
Schistosoma mansoni | apoferritin-2 | 0.001 | 0.1535 | 0.1746 |
Schistosoma mansoni | ferritin | 0.001 | 0.1535 | 0.1746 |
Mycobacterium tuberculosis | Probable bacterioferritin BfrA | 0.001 | 0.1535 | 0.5 |
Echinococcus multilocularis | ferritin | 0.001 | 0.1535 | 0.1535 |
Giardia lamblia | Flap structure-specific endonuclease | 0.0031 | 1 | 1 |
Mycobacterium tuberculosis | Bacterioferritin BfrB | 0.001 | 0.1535 | 0.5 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0031 | 1 | 1 |
Schistosoma mansoni | apoferritin-2 | 0.001 | 0.1535 | 0.1746 |
Wolbachia endosymbiont of Brugia malayi | bacterioferritin/cytochrome b1 | 0.001 | 0.1535 | 0.5 |
Treponema pallidum | bacterioferrin (TpF1) | 0.001 | 0.1535 | 0.5 |
Plasmodium falciparum | flap endonuclease 1 | 0.0031 | 1 | 1 |
Echinococcus granulosus | flap endonuclease 1 | 0.0031 | 1 | 1 |
Schistosoma mansoni | ferritin light chain | 0.001 | 0.1535 | 0.1746 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0031 | 1 | 1 |
Mycobacterium leprae | PROBABLE BACTERIOFERRITIN BFRA | 0.001 | 0.1535 | 0.5 |
Mycobacterium ulcerans | bacterioferritin BfrB | 0.001 | 0.1535 | 0.5 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0031 | 1 | 1 |
Schistosoma mansoni | ferritin | 0.001 | 0.1535 | 0.1746 |
Schistosoma mansoni | ferritin | 0.001 | 0.1535 | 0.1746 |
Schistosoma mansoni | flap endonuclease-1 | 0.0028 | 0.8794 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.631 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (binding) | = 0.7079 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.